insights_auto
Why is LYEL up 2.69%?
Dive Deeperchevron_right
LYEL:NASDAQ
Lyell Immunopharma Inc
$8.79
arrow_upward
+2.69%(+0.23) 1D
$8.79
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 8, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LYEL...
Open
$8.49
High
$8.84
Low
$8.21
Mkt. cap
215.40M
Avg. vol.
129.26K
Volume
194.72K
52-wk high
$45.00
52-wk low
$8.21
EPS
-$12.01
Beta
-0.03
Shares outstanding
24.50M
No. of employees
161
Open
$8.49
High
$8.84
Low
$8.21
Mkt. cap
215.40M
Avg. vol.
129.26K
Volume
194.72K
52-wk high
$45.00
52-wk low
$8.21
EPS
-$12.01
Beta
-0.03
Shares outstanding
24.50M
No. of employees
161
News stories
From web sources and news partners
Stock Traders Daily
·
18 hours ago
How (LYEL) Movements Inform Risk Allocation Models
https://www.dars.gov.et/
·
5 days ago
How Low Will Lyell (LYEL) Go After -1.59% Sell-Off? 2026-10-03 - Bullish Percent Index
Profile
Lyell Immunopharma, Inc. is an American clinical-stage biopharmaceutical company headquartered in San Francisco, California. Founded in 2018, the company develops next-generation cell therapies, including CAR T cell, using technologies intended to improve T-cell persistence, function, and resistance to exhaustion. Its pipeline includes therapies being developed for hematologic malignancies and solid tumors. Wikipedia
About Lyell Immunopharma Inc
CEO-
Employees161
Founded2018
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitelyell.com